Can a microRNA Control Inflammation in Patients With Ulcerative Colitis?

Loss of a non-coding RNA that regulates inflammation could contribute to development of ulcerative colitis (UC) in children, according to the October issue of Gastroenterology. UC and Crohn’s disease are chronic inflammatory bowel diseases that affect adults and children. These diseases are complex, and caused by combinations of genetic and

Read more

How Can the Gut Microbiota Contribute to Liver Disease?

Microbes that reside in colons of obese individuals produce many compounds that could contribute to development of non-alcoholic fatty liver disease (NAFLD) and other complications of obesity, according to a study published in the July issue of Clinical Gastroenterology and Hepatology. Microorganisms living in the human intestine (gut microbiota) affect

Read more

Is Medicine or Surgery the Best Treatment for Crohn’s Disease?

For patients with Crohn’s disease and intra-abdominal abscesses, nonsurgical and surgical management strategies result in similar rates of abscess recurrence and complications, according to the April issue of Clinical Gastroenterology and Hepatology. Crohn’s disease can progress from inflammation and ulceration to bowel damage that includes formation of abscesses, phlegmon, and

Read more

High Rate of Complications from Colectomy for Ulcerative Colitis

Twenty-seven percent of patients who are treated for ulcerative colitis by colectomy experience postoperative complications, according to a study in the November issue of Clinical Gastroenterology and Hepatology. Most patients with ulcerative colitis are successfully treated with medication, yet some have severe colitis attacks that can be life threatening. Approximately

Read more

An Immune Culprit in IBD?

Patients with Crohn’s disease or ulcerative colitis have reduced levels of an important regulator of the immune response—the receptor for granulocyte-macrophage colony-stimulating factor (GM-CSF)—according to a study by Jonathan Goldstein et al. in the July issue of Gastroenterology. The inflammatory bowel diseases (IBD) ulcerative colitis and Crohn’s disease arise from

Read more

Does Mucosal Healing Determine Which Patients Will Recover From Ulcerative Colitis?

Lack of mucosal healing, based on endoscopic analysis, identifies patients with ulcerative colitis (UC) who are not likely to respond to corticosteroid therapy, according to Sandro Ardizzone et al. in the June issue of Clinical Gastroenterology and Hepatology. In a prospective study, Ardizzone et al. followed 157 patients with moderate

Read more

Surviving Childhood Cancer Increases GI Risks

Individuals who received therapy for cancer during childhood have an increased risk of developing GI complications later in life, according to Robert Goldsby et al. in the May issue of Gastroenterology. About 80% of children who receive cancer therapy survive more than 5 years; therapies can be especially toxic to

Read more

Relief from Irritable Bowel Syndrome

Patients with irritable bowel syndrome (IBS) had significant improvements in bowel habits and reductions in abdominal pain after taking a new drug called linaclotide, reports a study published in the December issue of Gastroenterology. Jeffrey M. Johnston et al. performed a placebo-controlled phase 2 trial of 4 different doses of

Read more